Proteolix
Proteolix develops inhibitors of proteasome-medicated protein degradation in cells. Proteolix is dedicated to becoming the premier biopharmaceutical experts in this field developing novel inhibitors that regulate protein turnover for the treatment of important human diseases. Proteolix is also developing, in parallel, a strong internal program of research and pre-clinical development, and is focused on moving therapeutic agents into the clinic as quickly as possible.